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retina (Macosko et al., 2015). In addition
to measuring transcriptional output,
new methods have also been developed
to characterize transcriptional regula-
tion by measuring methylated DNA,
accessible chromatin, modified histones,
and chromatin conformation in single
cells (Schwartzman and Tanay, 2015).
Of course, technical hurdles remain.
Measuring genes expressed in single
cells is noisy, and existing methods suffer
from low sensitivity. Methods to charac-
terize chromatin in single cells are even
less mature and face harder limits on the
dynamic range of their measurements.
However, if history is a guide, these
methods will be improved rapidly and
together form a suite of tools to systemat-1310 Cell 163, December 3, 2015 ª2015 Elseically discover new cell types andmap the
genetic control of their phenotype and
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The fidelity of the intestinal barrier is critical to maintaining a healthy relationship between the
immune system and the microbiota. Levy et al. and Nowarski et al. reveal how microbiota-derived
metabolites modulate the activation of the inflammasome to influence the expression of the cyto-
kine IL-18, intestinal barrier function, and intestinal inflammation.The mucosal immune system has a
complex task, as it must be vigilant to
pathogens while maintaining cordial
relations with the relatively benign
commensal microbiota. To complicate
matters, inflammation in the intestine
can allow the outgrowth of aggressive
members of the microbiota, blurring the
lines between ‘‘pathogens’’ and ‘‘com-
mensals’’ and contributing to autoinflam-
matory conditions such as inflammatory
bowel disease (Dalal and Chang, 2014).
A primary mechanism of immune homeo-
stasis in the gut is to limit the interaction
with themicrobiota via the physical barrier
made of the intestinal epithelial cells
(IECs), anti-microbial proteins, and the
mucus, produced by goblet cells (Hooper
and Macpherson, 2010). The inflamma-
some, a macromolecular structure thatsupports the post-translational produc-
tion of the cytokines IL-1b and IL-18,
plays a critical role in supporting the intes-
tinal barrier. As a result, mice deficient in
inflammasome function and IL-18 pro-
duction develop an invasive dysbiotic mi-
crobiota that exacerbates pathology in
mouse models of chemically induced co-
litis (Elinav et al., 2013). Two papers in this
issue of Cell now better elucidate how
the inflammasome and microbiota
interact via sensing of metabolites to
induce IL-18 expression, modulate intes-
tinal barrier function, and intestinal inflam-
mation (Levy et al., 2015; Nowarski et al.,
2015).
Previous studies on mice deficient in
key components of the inflammasome
have indicated that this structure may
support goblet cell secretion and there-fore intestinal barrier function, indepen-
dent of the production of IL-18 (Wlodar-
ska et al., 2014). Levy et al. (2015) now
extend these findings to show that, at
steady state, signals from the microbiota
are necessary for inflammasome activa-
tion, IL-18 production, and the expression
of certain anti-microbial proteins (AMPs).
Critically, one of these AMPs, Ang4, is suf-
ficient to restore microbial diversity,
providing an explanation of how IL-18
supports the intestinal barrier and why
abrogation of IL-18 may lead to
commensal dysbiosis (see Figure 1). In
contrast, during instances of acute
inflammation, IL-18 may exacerbate dis-
ease. Using a series of genetic tools to
parse the role of IL-18 during chemically
induced colitis, Nowarski et al. (2015)
show that IL-18 signaling specifically
Figure 1. Role of Inflammasome and IL-18 in Barrier Function
(A) At steady state, a healthy bacterial microbiota produces metabolites, such as taurine, that support
inflammasome-mediated production of IL-18 and anti-microbial proteins in the colon that promote mi-
crobial diversity and prevent commensal dysbiosis.
(B) A dysbiotic microbiota is characterized by different metabolites, such as spermine, that inhibit the
inflammasome and inhibit anti-microbial protein production, allowing for its invasive character. During
inflammation-induced colitis, IL-18 prevents the development of goblet cells from uncommitted pre-
cursors, significantly reducing mucus production and intestinal barrier function.to the IECs is a critical driver of pathol-
ogy. The intestinal epithelium, including
the goblet cells, turns over rapidly,
with new cells developing from uncom-
mitted stem cell precursors. Interestingly,
IL-18 signaling specifically blocks the
development of goblet cells, leading to
reduced mucus in the colon and presum-
ably increased bacterial access to the
surface of the intestine (see Figure 1).
It was unclear how a disruption in the
dialog between the inflammasome and
the microbiota leads to invasive dysbio-
sis or even what microbiota-derived sig-
nals modulate the inflammasome. One
possibility was the sensing of ‘‘keystone
metabolites’’ derived from the micro-
biota that can act as surrogates of
commensal ecology (Belkaid and Hand,
2014). The best example of this phe-
nomenon is the sensing of short-chain
fatty acids (SCFA), which are bacterial
by-products of fiber metabolism and
induce regulatory immune responses
(Arpaia and Rudensky, 2014). SCFA
sensing by the inflammasome also has
been shown to bolster the intestinal bar-
rier (Macia et al., 2015). When Levy and
colleagues analyzed the metabolome of
their mouse models, they discoveredsignificant differences, notably that
taurine, a bile acid conjugate, is
decreased in the dysbiotic microbiota
while the polyamine metabolite spermine
is increased. These metabolites are
shown to have little effect on the micro-
biota but instead acted upon the stability
and function of the inflammasome posi-
tively (taurine) or negatively (spermine).
Thus, these results describe how collec-
tions of bacteria can modulate host im-
mune signaling by the production of
metabolites that either support or
disrupt intestinal function, in this case
via the inflammasome (see Figure 1).
This highlights the compelling idea that
certain configurations of the microbiota
may ‘‘highjack’’ the immune response
via metabolite production to induce an
environment conducive to their own
growth. It seems unlikely that the host
immune system would passively allow
this kind of negative manipulation, and
this type of metabolite/host interaction
may have evolved as part of a greater
response to enteric infections and other
severe perturbations of the microbiota.
Thus, the apparent invasiveness of dys-
biosis in these models may also be an
indicator of those bacteria that can sur-Cell 163, Dvive in a certain inflammatory environ-
ment associated with a particular disrup-
ted microbial metabolome. It will be of
tremendous interest to study how
various metabolites tune the immune
response, as this will allow for the iden-
tification of key biomarkers and thera-
peutics. Indeed, Levy et al. (2015) raise
the exciting possibility that administra-
tion of microbial metabolites such as
taurine could be therapeutic in patients
predisposed to IBD.
Taken together, these two papers
paint a complex portrait of IL-18 wherein
its role at steady state is to bolster the
barrier and prevent the outgrowth of
more aggressive members of the micro-
biota, but during instances of severe
inflammation, IL-18 expression leads to
a loss of goblet cells, depleting barrier
function. While it is clear that the effects
of IL-18 in driving pathology during colitis
are directed to IECs, the cellular targets
and key signaling components of IL-18
in controlling the microbiota and mucosal
immunity are not. For example, in
contrast to germline IL-18 knockout ani-
mals, IEC-specific knockouts of IL-18
and IL-18R1 do not develop a microbiota
that predisposes to colitis. As further
illustration of the pleiotropic effects of
IL-18 in the gut, in a T-cell-driven model
of colitis, IL-18R1 expression on T cells
is critical to both suppress IL-17 produc-
tion and the function of regulatory T cells
(Harrison et al., 2015). Finally, these two
papers underscore the difficulties facing
our understanding of autoinflammatory
disorders at barrier sites that exist at
the confluence of three interdependent
factors: host genome, the metagenome
of the microbiota, and the environment,
all of which are unique to an individual.
It is only through holistic studies of how
host genetics interact with the micro-
biome and metabolome that we will un-
derstand the etiology of these complex
diseases.REFERENCES
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Understanding the molecular basis underlying aging is critical if we are to fully understand how
and why we age—and possibly how to delay the aging process. Up until now, most longevity path-
ways were discovered in invertebrates because of their short lifespans and availability of genetic
tools. Now, Reichwald et al. and Valenzano et al. independently provide a reference genome for
the short-lived African turquoise killifish, establishing its role as a vertebrate system for aging
research.Human aging is associated with repro-
ductive and cognitive decline and an
increased risk of cancer, diabetes, cardio-
vascular disease, and neurodegenerative
disease. The discovery of long-lived mu-
tants demonstrated that aging is a genet-
ically regulated process. Most molecular
insights into the biology of aging come
from short-lived invertebrates, such as
C. elegans and Drosophila (with lifespans
of 3 weeks and 3 months, respectively),
or single-celled organisms like Saccharo-
myces cerevisiae. For example, the insu-
lin/IGF-1 signaling pathway, which plays
a conserved role in lifespan regulation
from yeast to humans, was first discov-
ered inC. elegans; mutants of the daf-2 in-
sulin receptor double lifespan (Kenyon
et al., 1993). Other pathways that modu-
late lifespan, including the nutrient-
sensing TOR pathway, the HSF-1 heat
shock pathway, and the JNK stress
response pathway, were also discovered
in these systems. Vertebrate model sys-
tems, such as zebrafish and mouse,
have also been used to study aging and
age-related decline, but their long life-
spans (3.5 and 5 years, respectively;Figure 1), make it difficult to rapidly
conduct complex aging experiments.
Thus, the establishment of a short-lived
genetic and genomic model system
would allow both testing of conserved
pathways and the discovery of new
longevity regulators. While the African tur-
quoise killifish Nothobranchius furzeri has
been recognized for its potential for aging
research (Genade et al., 2005; Valenzano
et al., 2006; Di Cicco et al., 2011, Kirsch-
ner et al., 2012, Harel et al., 2015), until
now, its utility has been limited because
of the lack of genomic resources. In this
issue of Cell, two independent groups,
Reichwald et al. (2015) and Valenzano
et al. (2015), map the genome of this
short-lived fish and bridge this gap.
Nothobranchius furzeri is a short-lived
vertebrate that lives in seasonal freshwater
ponds in Zimbabwe and Mozambique
(Genade et al., 2005). In laboratory condi-
tions, N. furzeri exhibit a maximal lifespan
of 4—6 months, making them the short-
est-lived vertebrate that can be bred in
captivity. They also exhibit age-related de-
clines in fertility and cognitive ability, as
well as age-related telomere shortening,impaired mitochondrial function, and can-
cer (Genade et al., 2005; Valenzano et al.,
2006; Di Cicco et al., 2011), making them
an idealmodel system for lifespan studies.
Indeed, N. furzeri have previously been
used for mapping quantitative trait loci
that control lifespan (Kirschner et al.,
2012).
Here, Reichwald et al. and Valenzano
et al., describe their independent work to
generate a reference genome for the high-
ly inbred GRZ strain of N. furzeri. The
authors then use the new genome infor-
mation to provide novel insights into life-
span regulation and sex determination.
Upon genome assembly and annotation,
Valenzano et al. identified 497 genes un-
der positive selection in the GRZ refer-
ence strain. These include genes associ-
ated with longevity in humans (IGFR1,
INSRA, LMNA3, and XRCC5). Further,
they found that distinct residues are under
positive selection in humans versus tur-
quoise killifish, suggesting that variants
of the same gene might confer context-
dependent short or long lifespans in tur-
quoise killifish and humans, respectively.
They also sequenced two longer-lived
